| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 02/14/2002 | WO2002011767A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 02/14/2002 | WO2002011531A1 Device for treating dung with the aid of larvae of synanthropic flies |
| 02/14/2002 | WO2002011530A1 Transgenic animal |
| 02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001040765A3 Improved flow cytometer nozzle and flow cytometer sample handling methods |
| 02/14/2002 | WO2000065062A3 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 02/14/2002 | WO2000060933A9 Pkc induced targets |
| 02/14/2002 | US20020019992 Transgenic non-human mammals with progressive neurologic disease |
| 02/14/2002 | US20020019653 Methods and devices for manipulating thermoregulatory status of a mammal |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020018778 Passive desensitization |
| 02/14/2002 | CA2634294A1 Production of humanized antibodies in transgenic animals |
| 02/14/2002 | CA2422155A1 Production of humanized antibodies in transgenic animals |
| 02/14/2002 | CA2418952A1 A novel member of the lysyl oxidase gene family |
| 02/14/2002 | CA2418779A1 Schizophrenia related gene and protein |
| 02/14/2002 | CA2417909A1 Isolation and use of solid tumor stem cells |
| 02/14/2002 | CA2417595A1 Cryopreservation of sperm |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |
| 02/13/2002 | EP1179053A1 Telophase enucleated oocytes for nuclear transfer |
| 02/13/2002 | EP1179021A1 Human gaba b receptor 1 promoters |
| 02/13/2002 | EP1178835A1 Compositions and methods for improving learning and memory |
| 02/13/2002 | EP1178814A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders |
| 02/13/2002 | EP1178722A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING |
| 02/13/2002 | EP0971603B1 Artificial media for rearing entomophages |
| 02/13/2002 | CN1335060A Biotechnological embryo process for breeding cow |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010337A2 Method of cloning porcine animals |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002009736A1 Methods and agents for treating persistent pain |
| 02/07/2002 | WO2002009650A2 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 02/07/2002 | WO2002009641A2 Promyostatin peptides and methods of using same |
| 02/07/2002 | WO2002009510A2 Methods of selecting and cloning animals |
| 02/07/2002 | WO2002009509A2 Inhibition of gene expression using polynucleotide analogues |
| 02/07/2002 | WO2002009508A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 02/07/2002 | WO2002009507A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 02/07/2002 | WO2001072119A3 Non-human animal model for growth deficiency and information processing or cognitive function defects and use thereof |
| 02/07/2002 | WO2001029255A9 Diagnostic test for cephalic pain |
| 02/07/2002 | WO2001024781A3 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 02/07/2002 | WO2001001150A3 Diagnostic test for thrombotic or thromboembolic disease |
| 02/07/2002 | US20020016978 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
| 02/07/2002 | US20020016977 Method for production of a transgenic animal, and a transgenic animal produced by the method |
| 02/07/2002 | US20020016976 Mutant multi-substrate enzyme which accepts at least one orthogonal substrate analog, whereby catalytic activity results in combination of all or part of orthogonal substrate with other substrate of enzyme; drug screening |
| 02/07/2002 | US20020016975 Nucletide sequences for use as tools in genetic engineering; for use in gene therapy |
| 02/07/2002 | US20020016974 Transgenic, non-human animals containing a coxsackie/adenovirus receptor (CAR) |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | DE10053879A1 Genexpression, Genomalteration und Reporterexpression in Myofibroblasten und myofibroblast-ähnlichen Zellen Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | CA2417345A1 Method of cloning porcine animals |
| 02/07/2002 | CA2416877A1 Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 02/07/2002 | CA2416260A1 Promyostatin peptides and methods of using same |
| 02/07/2002 | CA2416186A1 Inhibition of gene expression using polynucleotide analogues |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1177445A1 Methods for screening gaba-modulatory compounds for specified pharmacological activities |
| 02/06/2002 | EP1177435A1 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177012A1 Method and apparatus for inducing ventricular arrhythmias in test animals |
| 02/06/2002 | CN2475283Y Foldable lavarium of lapidoptera insect suitable for industrialized production |
| 02/06/2002 | CN1334878A Polynucleotide comprising ubiquitous chromatin opening element (UCDE) |
| 02/06/2002 | CN1334870A Mammalian transgenesis by intracytoplasmic sperm injection |
| 02/05/2002 | US6344596 Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344324 Quantification of cellular injury using expression of a fluorescent protein under the control of the GADD153 promoter |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 01/31/2002 | WO2002008442A2 Means and methods for raising antibody concentration in compartments of the body of a non human animal |
| 01/31/2002 | WO2002008407A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/31/2002 | WO2002008405A1 Isocitrate dehydrogenases, their genes, and use in antioxidative system suppressive of ros-mediated diseases |
| 01/31/2002 | WO2002008401A2 Elongase genes and uses thereof |
| 01/31/2002 | WO2002008388A2 Stem cell-like cells |
| 01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002007754A2 New use |
| 01/31/2002 | WO2002007752A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001034801A3 Recombinant gelatin in vaccines |
| 01/31/2002 | WO2000047219A3 Methods and reagents for treating glucose metabolic disorders |
| 01/31/2002 | US20020013957 Genetically engineering swine embryos; culture swine embryos, translocate nucleus to another swine embryo, activate oocyte, monitor embryo development |
| 01/31/2002 | US20020013953 Transgenic mammal; for use as model in evaluating lysosomal storage defects |
| 01/31/2002 | US20020013952 Self-contained system for sustained viral replication |
| 01/31/2002 | US20020012996 Mutating genes; mix cell and vector, transform mammalian cells, recover cells |
| 01/31/2002 | US20020012984 Genetic engineering |
| 01/31/2002 | US20020012905 Generating profile of preferential chemical intermediates; incubate liver stem cells with chemical intermediate, monitor cells, detect adjustments in gene expression, classify respones to chemical intermediate |
| 01/31/2002 | US20020012660 Method of preparing a somatic cells for nuclear transfer |
| 01/31/2002 | US20020012655 Administering to or transplanting into least one cell or tissue obtained from cloned ungulate animal or embryo for therapy |
| 01/31/2002 | DE10033750A1 Pathogenresistenz in Organismen Pathogen resistance in organisms |
| 01/31/2002 | CA2418215A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | CA2416682A1 Stem cell-like cells |
| 01/31/2002 | CA2416381A1 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |